The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria

Johan W. Jonker(Slotervaartziekenhuis), Marije Buitelaar(Slotervaartziekenhuis), Els Wagenaar(Slotervaartziekenhuis), Martin A. van der Valk(Slotervaartziekenhuis), George L. Scheffer(Slotervaartziekenhuis), Rik J. Scheper(Slotervaartziekenhuis), Torsten Plösch(Slotervaartziekenhuis), Folkert Kuipers(Slotervaartziekenhuis), Ronald P.J. Oude Elferink(Slotervaartziekenhuis), Hilde Rosing(Slotervaartziekenhuis), Jos H. Beijnen(Slotervaartziekenhuis), Alfred H. Schinkel(Slotervaartziekenhuis)
Proceedings of the National Academy of Sciences
November 12, 2002
Cited by 820Open Access
Full Text

Abstract

The breast cancer resistance protein (BCRPABCG2) is a member of the ATP-binding cassette family of drug transporters and confers resistance to various anticancer drugs. We show here that mice lacking Bcrp1Abcg2 become extremely sensitive to the dietary chlorophyll-breakdown product pheophorbide a, resulting in severe, sometimes lethal phototoxic lesions on light-exposed skin. Pheophorbide a occurs in various plant-derived foods and food supplements. Bcrp1 transports pheophorbide a and is highly efficient in limiting its uptake from ingested food. Bcrp1(-/-) mice also displayed a previously unknown type of protoporphyria. Erythrocyte levels of the heme precursor and phototoxin protoporphyrin IX, which is structurally related to pheophorbide a, were increased 10-fold. Transplantation with wild-type bone marrow cured the protoporphyria and reduced the phototoxin sensitivity of Bcrp1(-/-) mice. These results indicate that humans or animals with low or absent BCRP activity may be at increased risk for developing protoporphyria and diet-dependent phototoxicity and provide a striking illustration of the importance of drug transporters in protection from toxicity of normal food constituents.


Related Papers

No related papers found

Powered by citation graph analysis